PTPRC and neoplasm: Each ROI was divided into three areas of interest (AOIs) based on fluorescent‐labeled visualization antibodies, including PANCK+ (tumor cell cluster), CD45+ (immune cell cluster), and CD45−/PANCK− (stromal cell cluster) regions (Figure 1B).